BioVie Inc. Increase (Decrease) in Other Operating Liabilities
BioVie Inc. (BIVI) reported Increase (Decrease) in Other Operating Liabilities of -$48.38 thousand for the 12-month period ending 2024-06-30, per its S-1/A filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-06
- BioVie Inc. increase (decrease) in other operating liabilities for the quarter ending 2024-06-30 was $0.00.
- BioVie Inc. increase (decrease) in other operating liabilities for the quarter ending 2024-03-31 was $0.00.
- BioVie Inc. increase (decrease) in other operating liabilities for the quarter ending 2023-12-31 was $0.00.
- BioVie Inc. increase (decrease) in other operating liabilities for the quarter ending 2023-09-30 was -$48.38K.
- BioVie Inc. increase (decrease) in other operating liabilities for fiscal 2023 was -$1.30M, a 196.42% decline from fiscal 2022.
- BioVie Inc. increase (decrease) in other operating liabilities for fiscal 2022 was $1.35M.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2024-06-30 | $0.00 derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | -$48.38K S-1/A · filed 2026-08-06 |
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-12 | $0.00 derived: sum of 2 quarters · filed 2025-05-12 | -$48.38K 10-Q · filed 2025-05-12 | -$193.54K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-11 | -$48.38K 10-Q · filed 2025-02-11 | -$193.54K derived: sum of 3 quarters · filed 2025-02-11 | -$338.70K derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-09-30 | -$48.38K 10-Q · filed 2024-11-13 | -$193.54K derived: sum of 2 quarters · filed 2024-11-13 | -$338.70K derived: sum of 3 quarters · filed 2024-11-13 | -$483.85K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$145.16K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | -$290.31K derived: sum of 2 quarters · filed 2024-09-30 | -$435.47K derived: sum of 3 quarters · filed 2024-09-30 | -$1.30M 10-K · filed 2024-09-30 |
| 2023-03-31 | -$145.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-14 | -$290.31K derived: sum of 2 quarters · filed 2024-05-14 | -$1.16M 10-Q · filed 2024-05-14 | -$580.63K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$145.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13 | -$1.01M 10-Q · filed 2024-02-13 | -$435.47K derived: sum of 3 quarters · filed 2024-02-13 | -$580.63K derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-09-30 | -$869.46K 10-Q · filed 2023-11-08 | -$290.31K derived: sum of 2 quarters · filed 2023-11-08 | $774.17K 10-Q · filed 2022-05-11 | -$580.63K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $579.14K derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-16 | $433.99K derived: sum of 2 quarters · filed 2023-08-16 | $288.83K derived: sum of 3 quarters · filed 2023-08-16 | $1.35M 10-K · filed 2023-08-16 |
| 2022-03-31 | -$145.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-12 | -$290.31K derived: sum of 2 quarters · filed 2023-05-12 | $774.17K 10-Q · filed 2023-05-12 | |
| 2021-12-31 | -$145.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-10 | $919.32K 10-Q · filed 2023-02-10 | ||
| 2021-09-30 | $1.06M 10-Q · filed 2022-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |